Cargando…

Somatotroph-Specific Aip-Deficient Mice Display Pretumorigenic Alterations in Cell-Cycle Signaling

Patients with familial isolated pituitary adenoma are predisposed to pituitary adenomas, which in a subset of cases is due to germline inactivating mutations of the aryl hydrocarbon receptor–interacting protein (AIP) gene. Using Cre/lox and Flp/Frt technology, a conditional mouse model was generated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillam, Mary P., Ku, Cheol Ryong, Lee, Yang Jong, Kim, Jean, Kim, Se Hoon, Lee, Sue Ji, Hwang, Byungjin, Koo, JaeHyung, Kineman, Rhonda D., Kiyokawa, Hiroaki, Lee, Eun Jig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686555/ https://www.ncbi.nlm.nih.gov/pubmed/29264469 http://dx.doi.org/10.1210/js.2016-1004

Ejemplares similares

Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line
por: Fukuda, Takashi, et al.
Publicado: (2016)

Olfactory marker protein regulates prolactin secretion and production by modulating Ca(2+) and TRH signaling in lactotrophs
por: Kang, Chan Woo, et al.
Publicado: (2018)

Olfactory Marker Protein Expression Is an Indicator of Olfactory Receptor-Associated Events in Non-Olfactory Tissues
por: Kang, NaNa, et al.
Publicado: (2015)

Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer
por: Lee, Hyeon Jeong, et al.
Publicado: (2023)

Olfactory marker protein regulation of glucagon secretion in hyperglycemia
por: Oh, Ju Hun, et al.
Publicado: (2022)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab 2016;31:328-35, Cheol Ryong Ku et al.)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

Change in the immunophenotype of a somatotroph adenoma resulting in gigantism
por: Thawani, Jayesh P., et al.
Publicado: (2014)

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

Clinically silent somatotroph adenomas are common
por: Wade, Alisha N, et al.
Publicado: (2011)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

Characteristics of Acromegaly in Korea with a Literature Review
por: Hong, Jae Won, et al.
Publicado: (2013)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019)

Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality
por: Kim, Eui Hyun, et al.
Publicado: (2023)

Somatotroph Tumors and the Epigenetic Status of the GNAS Locus
por: Romanet, Pauline, et al.
Publicado: (2021)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
por: Ku, Cheol Ryong, et al.
Publicado: (2020)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Endotoxin Triggers Tumor Initiation Events in Nontumorigenic Breast Epithelial Cells and Enhances Invasion-Related Phenotype in Pretumorigenic and Tumorigenic Breast Epithelial Cells
por: Yassine, Farah, et al.
Publicado: (2021)

Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
por: Kim, Hae-Kyung, et al.
Publicado: (2021)

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience
por: Hong, Seung Woo, et al.
Publicado: (2021)

SUN-446 Association between Prolactin Level and Tumor Size Reduction at 3 Months after Cabergoline Treatment in Patients with Macroprolactinoma
por: Kim, Daham, et al.
Publicado: (2019)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
por: Lee, Youngki, et al.
Publicado: (2014)

Thyrotropinoma with silent somatotroph and lactotroph adenoma during pregnancy
por: Wu, Yu-Fang, et al.
Publicado: (2022)

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

AIP Annual Meeting
por: Abashian, Alexander
Publicado: (1984)

AIP Annual Meeting
por: Margolis, Bernard, et al.
Publicado: (1980)

AIP Annual Meeting
por: Caswell, William E, et al.
Publicado: (1983)

AIP Annual Meeting
por: Heusch, Clemens A, et al.
Publicado: (1982)

AIP Annual Meeting
por: Carlson, Carl E
Publicado: (1975)

AIP Congress 2006
Publicado: (2006)

The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Treating age-related changes in somatotrophic hormones, sleep, and cognition
por: Vitiello, Michael V., et al.
Publicado: (2001)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Pituitary Somatotroph Adenoma-derived Exosomes: Characterization of Nonhormonal Actions
por: Zhou, Cuiqi, et al.
Publicado: (2021)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dhl2f40idnfsft3g94vk0hrg6m